RT Journal Article
SR Electronic
T1 Development and testing of reduced versions of the MMT-8 in juvenile dermatomyositis
JF The Journal of Rheumatology
JO J Rheumatol
FD The Journal of Rheumatology
SP jrheum.200543
DO 10.3899/jrheum.200543
A1 Silvia Rosina
A1 Giulia Camilla  Varnier
A1 Angela Pistorio
A1 Clarissa Pilkington
A1 Susan Maillard
A1 Adele Civino
A1 Elena Tsitsami
A1 Claudia Bracaglia
A1 Marija Jelusic
A1 Adriana Cespedes-Cruz
A1 Graciela Espada
A1 Rolando Cimaz
A1 Gerard Coutillault
A1 Rik Joos
A1 Pierre Quartier
A1 Anand Prahalad  Rao
A1 Clara Malattia
A1 Nicolino Ruperto
A1 Alessandro Consolaro
A1 Angelo Ravelli
YR 2020
UL http://www.jrheum.org/content/early/2020/11/10/jrheum.200543.abstract
AB Objective To develop and test shortened versions of Manual Muscle Testing-8 (MMT-8) in juvenile dermatomyositis (JDM). Methods Construction of reduced tools was based on retrospective analysis of individual scores of MMT-8 muscle groups in three multinational datasets. The 4 and 6 most frequently impaired muscle groups were included in MMT-4 and MMT-6, respectively. Metrologic properties of reduced tools were assessed by evaluating construct validity, internal consistency, discriminant ability, and responsiveness to change. Results Neck flexors, hip extensors, hip abductors and shoulder abductors were included in MMT-4, whereas MMT-6 also included elbow flexors and hip flexors. Both shortened tools revealed strong correlations with MMT-8 and other muscle strength measures. Correlations with other JDM outcome measures were in line with predictions. Internal consistency was good (0.88-0.96) for both MMT-4 and MMT-6. Both reduced tools showed strong ability to discriminate between disease activity states, assessed by the caring physician or a parent (p < 0.001), and between patients whose parents were satisfied or not satisfied with illness course (p < 0.001). Responsiveness to change (assessed by both standardized response mean and relative efficiency) of MMT-4 and, to a lesser degree, MMT-6, was slightly superior to that of MMT-8. Conclusion The metrologic performance of MMT-4 and MMT-6 was overall comparable to that of the other established muscle strength tools, which indicate that they may be suitable for use in clinical practice and research, including clinical trials. The measurement properties of these tools should be further tested in other patient populations evaluated prospectively.